CR Biotech is a Boston-based venture capital investor backing clinical-stage life sciences companies, including pharmaceutical, diagnostic and medical technology businesses seeking trial funding. The firm invests worldwide, including the United States and Europe, and does not target purely pre-clinical rounds. Its activity includes later-stage venture biotechnology investing, with a broader focus across biotechnology, life sciences, medical devices and pharmaceuticals.